Women’s Health Initiative Studies of Postmenopausal Breast Cancer

  • Ross L. Prentice
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 617)

The Women’s Health Initiative (WHI) is a major population research enterprise that aims to generate knowledge and recommendations pertinent to the health of postmenopausal women. The WHI is funded and administered through the USA National Institutes of Health, with the National Heart Lung and Blood Institute having a central role. The WHI is conducted through 40 Clinical Centers in the USA. Our group at the Fred Hutchinson Cancer Research Center in Seattle serves as Clinical Coordinating Center for the WHI, and as the site for one of the Clinical Centers.


Breast Cancer Postmenopausal Hormone Therapy Abnormal Mammogram Hormone Therapy Trial Dietary Modification Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333.CrossRefGoogle Scholar
  2. 2.
    The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial. JAMA 291:1701–1712.CrossRefGoogle Scholar
  3. 3.
    Prentice RL, Caan B, Chlebowski RT, et al. (2006) Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:629–642.PubMedCrossRefGoogle Scholar
  4. 4.
    Jackson RD, LaCroix AZ, Gass M, et al. (2006) Calcium plus vitamin D supplementation and the risk for fractures. N Engl J Med 354:669–683.PubMedCrossRefGoogle Scholar
  5. 5.
    Wactawski-Wende J, Kotchen JM, Anderson GL, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684–696.PubMedCrossRefGoogle Scholar
  6. 6.
    Chlebowski RT, Hendrix SL, Langer RD, et al. (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA 289:3243–3253.PubMedCrossRefGoogle Scholar
  7. 7.
    Anderson GL, Chlebowski RT, Rossouw JE, et al. (2006) Prior hormone therapy and breast cancer risk in the Women’s Health Initiative randomized trial of estrogen plus progestin. Maturitas 55:103–115.PubMedCrossRefGoogle Scholar
  8. 8.
    Stefanick ML, Anderson GL, Margolis KL, et al. (2006) Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295:1647–1657.PubMedCrossRefGoogle Scholar
  9. 9.
    Chen WY, Manson JE, Hankinson SE, et al. (2006) Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med 166:1027–1032.PubMedCrossRefGoogle Scholar
  10. 10.
    Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419–427.PubMedCrossRefGoogle Scholar
  11. 11.
    Howe GR, Hirohata T, Hislop TG, et al. (1990) Dietary factors and risk of breast cancer: combined analysis of 12 case–control studies. J Natl Cancer Inst 82:561–569.PubMedCrossRefGoogle Scholar
  12. 12.
    Hunter DJ, Spiegelman D, Adami HO, et al. (1996) Cohort studies of fat intake and the risk of breast cancer – a pooled analysis. N Engl J Med 334:356–361.PubMedCrossRefGoogle Scholar
  13. 13.
    Insull W, Henderson MM, Prentice RL, et al. (1990) Results of a randomized feasibility study of a low-fat diet. Arch Intern Med 150:421–427.PubMedCrossRefGoogle Scholar
  14. 14.
    Prentice RL, Thompson DJ, Clifford C, et al. (1990) Dietary fat reduction and plasma estradiol concentration among healthy postmenopausal women. J Natl Cancer Inst 82:129–134.PubMedCrossRefGoogle Scholar
  15. 15.
    Prentice RL, Qi L (2006) Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. Biostatistics 7:339–354.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang H, Clouthier SG, Galchev V, et al. (2005) Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 4:618–625.PubMedCrossRefGoogle Scholar
  17. 17.
    Freedman LS, Potischman N, Kipnis V, et al. (2006) A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epid 35:1011–1021.CrossRefGoogle Scholar
  18. 18.
    Bingham SA, Luben R, Welch A, et al. (2003) Are imprecise methods obscuring a relationship? Report from the EPIC Norfolk Prospective Cohort Study. Lancet 362:212–214.PubMedCrossRefGoogle Scholar
  19. 19.
    Bingham SA, Day N (2006) Commentary: Fat and breast cancer: time to re-evaluate both methods and results? Int J Epid 35:1022–1024.CrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Ross L. Prentice
    • 1
  1. 1.Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations